Human movement company Scientific Analytics Inc reported on Wednesday the receipt of the US FDA's 510K medical device designation for its computer-vision-powered motion health analysis technology, DARI Health.
According to the company, its markerless DARI Motion computer vision and biomechanical analysis technology has been refined by more than 425bn data points of human motion gathered across applications in wellness, military, elite athletics and healthcare. It helps people and organisations to improve performance, avoid injury and reduce unnecessary costs.
Scientific Analytics has also formed a strategic collaboration with Hospital for Special Surgery (HSS), the world's largest academic musculoskeletal health company.
The newly formed partnership will integrate leading knowledge and technology with the aim of setting new standards for full-body, dynamic motion analysis at population scale. It will provide the first medical device that will arm clinicians with an FDA-cleared, accurate and reliable solution that easily and seamlessly captures clinically-relevant human movement data at the point of care.
Through the partnership, the companies aim to create a new standard in data-driven, value-based musculoskeletal health while objectively documenting outcomes and delivering an engaging patient experience.
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics
Saluda Medical secures CE certification for EVA Sensing Technology in Europe